Sfoglia per AUTORE
TRABOULSEE A
Collezione AOU San Luigi di Orbassano

  

Items : 3

Myelin-oligodendrocyte glycoprotein antibody-associated disease. in The Lancet. Neurology / Lancet Neurol. 2021 Sep;20(9):762-772. doi: 10.1016/S1474-4422(21)00218-0.
2021
AOU San Luigi di Orbassano

Marignier R; Hacohen Y; Cobo-Calvo A; Pröbstel AK; Aktas O; Alexopoulos H; Amato MP; Asgari N; Banwell B; Bennett J; Brilot F; Capobianco M; Chitnis T; Ciccarelli O; Deiva K; De Sèze J; Fujihara K; Jacob A; Kim HJ; Kleiter I; Lassmann H; Leite MI; Linington C; Meinl E; Palace J; Paul F; Petzold A; Pittock S; Reindl M; et alii...

Treatment of MOG antibody associated disorders: results of an international survey. in Journal of neurology / J Neurol. 2020 Dec;267(12):3565-3577. doi: 10.1007/s00415-020-10026-y. Epub 2020 Jul 4.
2020
AOU San Luigi di Orbassano

Whittam DH; Karthikeayan V; Gibbons E; Kneen R; Chandratre S; Ciccarelli O; Hacohen Y; de Seze J; Deiva K; Hintzen RQ; Wildemann B; Jarius S; Kleiter I; Rostasy K; Huppke P; Hemmer B; Paul F; Aktas O; Pröbstel AK; Arrambide G; Tintore M; Amato MP; Nosadini M; Mancardi MM; Capobianco M; Illes Z; Siva A; Altintas A; Akman-Demir G; et alii...

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings. in Frontiers in neurology / Front Neurol. 2019 Mar 22;10:253. doi: 10.3389/fneur.2019.00253. eCollection 2019.
2019
AOU San Luigi di Orbassano

Barclay K; Carruthers R; Traboulsee A; Bass AD; LaGanke C; Bertolotto A; Boster A; Celius EG; de Seze J; Cruz DD; Habek M; Lee JM; Limmroth V; Meuth SG; Oreja-Guevara C; Pagnotta P; Vos C; Ziemssen T; Baker DP; Wijmeersch BV;